Board of Directors

Mr. Williams has more than 40 years of experience in the accounting and finance sector, including 36 years in the public accounting industry and over four years serving on the board of various public and private companies. His public accounting experience includes 18 years as a partner with Ernst & Young, and seven years as a partner with Grant Thornton. With a primary industry focus in the life sciences/healthcare and technology sectors, he served companies involved in the extended care market, acute care market, and roll-up transactions involving physicians, dentists and ambulatory surgery centers while at Ernst & Young. During his time at Grant Thornton, he served as national leader of the life sciences industry sector and managing partner of the San Diego Office. From 2001 to 2014, Mr. Williams served on the board of directors of the San Diego Venture Group, during which time he also served as the group’s President and Chairman. He was also a founding member of the Young VCs of Southern California.

Mr. Williams currently serves on the board of directors of Adhera Therapeutics, Akari Therapeutics, Alphatec Spine, and ImpediMed. He received a Bachelor’s degree in Accountancy from Southern Illinois University and completed the director education and certification program at the University of California, Los Angeles (UCLA) Anderson School of Business.

Mr. Finley is an experienced financial executive, having played instrumental roles in raising nearly $1 billion in capital for companies as both an internal Chief Financial Officer (CFO) and an independent investment banker. Prior to joining Palisade Bio (formerly Leading BioSciences) as the company’s CFO, Mr. Finley was the Chief Executive Officer, President and CFO for PointAcross, Inc., a software company providing business messaging and communications services. Mr. Finley previously co-founded Proteus Capital Partners, Inc., a firm specializing in providing financing for a variety of businesses, and was a Principal and CFO at Phillips Capital, a broker/dealer firm specializing in private debt and equity capital raises. During his career, he also served as Executive Vice President and CFO of MetroGolf, Inc., where he successfully completed MetroGolf’s initial public offering and was instrumental in growing the start-up company to over 125 employees. Mr. Finley began his business career as a tax specialist with Deloitte & Haskins and Sells (now Deloitte LLP), and later was co-owner of Mitchell Finley & Company, a full-service accounting firm.

Mr. Finley earned a Bachelor’s degree in Business Administration from Boise State University and a Master’s degree in Taxation from the University of Denver.

Ms. Fischbein is a highly experienced healthcare investment banker and accomplished biotechnology industry executive. Ms. Fischbein currently serves as Managing Director, Healthcare, for Cassel Salpeter & Co., an independent investment banking firm. Previously, Ms. Fischbein was Head of Healthcare Investment Banking for Seaport Global and for FBR & Co. and Head of East Coast Biotechnology Investment Banking for JMP Securities. Prior to rejoining the banking industry, Ms. Fischbein held senior corporate positions at ImClone Systems and Human Genome Sciences. Early in her career, Ms. Fischbein was senior vice president at Lehman Brothers, and then was a Managing Director of investment banking at the Chase Manhattan Corporation and at Citigroup. Ms. Fischbein earned a Master’s degree in Business Administration from Harvard Business School and a Bachelor’s degree in Economics from Harvard University.

Mr. Binxian (Phil) Wei has served on our board of directors since February 2019. He has been the V.P. of Darsheng Trade & Tech. Development Co, Ltd. (a subsidiary to Tianjin Tiayo Pharmaceutical Co., Ltd.) since 2015. He is responsible for API and finished dosage marketing for Chinese pharmaceutical companies. From 2008 through 2010, he worked as a business development manager for Sakai Trading.

He holds a Master’s degree in Mathematical & Computer Sciences from Colorado School of Mines, a Master’s and Bachelor’s degree in Chemical Engineering from Tianjin University in China.